Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
Physicians' Offices
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer. 2018 01 22; 18(1):87.
View in:
PubMed
subject areas
Aged
Animals
Antigens, Neoplasm
Caenorhabditis elegans
CD8-Positive T-Lymphocytes
Chickens
Female
Gene Expression Regulation, Neoplastic
Genome
High-Throughput Nucleotide Sequencing
Humans
Macrophages
Middle Aged
Mutation
Neoplasm Recurrence, Local
Neoplastic Stem Cells
Ovarian Neoplasms
Platinum
authors with profiles
Jeffrey E. Hammerbacher